The combination of stereotactic RT or radiosurgery with immunotherapy or targeted therapy shows manageable toxicity and improved local control and clinical benefit in patients with brain metastases. Medscape News UK
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
When Heavy or Light Periods Signal Reproductive Risk
Heavy or scant menses often reflect ovulatory, uterine, or hormonal disorders that can indirectly impair conception; targeted evaluation identifies treatable causes to protect fertility. Medscape News Europe
-
Promoting Whole-Body Imaging: Not There Yet
Ethicist Art Caplan discusses marketing promotions for expensive whole-body imaging. Medscape Business of Medicine
-
Medicine Will Turn Cellular Age Backward by 2050: Barzilai
Aging may not be permanent. Nir Barzilai explains how human cells reset to zero and why partial rejuvenation could be possible within decades. Medscape
-
Updated HEART Score Enhances CAD Prediction Accuracy of CCTA
Integrating male sex, RBBB, and haemoglobin and glucose levels into the HEART score improves its ability to predict significant coronary artery disease on CCTA in the emergency department setting. Medscape News UK
-
Stereotactic Radiation Linked to Better Brain Mets Outcomes
Researchers compared outcomes of stereotactic radiation and hippocampal-avoidance whole brain radiation in patients with 5-20 brain metastases. Medscape Medical News
-
PSMA PET: Prostate Cancer Staging Revolution Awaits RCT Data
‘Step by step, little by little, we are learning how to act on this new staging information,’ one investigator says. Medscape Medical News
-
Systemic Inflammation in Heart Failure
A study on the prevalence and correlates of high-sensitivity C-reactive protein ≥2 mg/L. across the spectrum of HF using date from 3 major trials: SELECT, SOUL, and FLOW. JACC: Heart Failure
-
Barrett’s Esophagus Guidance Emphasizes Risk Stratification
Emphasis has shifted to high-quality endoscopy based on patient risk stratification. Medscape Medical News
-
Which Salvage Therapy Is Best for Recurrent Prostate Cancer?
Ten-year survival data support salvage focal therapy as an option for patients with localized recurrence after prostate cancer radiotherapy. Medscape Medical News